Relationships among bleeding severity, health‐related quality of life, and platelet count in children with immune thrombocytopenic purpura

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Pediatric Blood & Cancer

• Publication date

  2009-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pbc.21978PMID 19492316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A cost‐utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP)

  2007cited by this paper
• Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP Tools.

  2007cited by this paper
• New thrombopoietic growth factors.

  2007cited by this paper
• Quantitative Assessment of Drug Treatment Side Effects in Children with Idiopathic Thrombocytopenic Purpura (ITP).

  2004cited by this paper
• Pediatr Blood Cancer

  2004cited by this paper
• Development of Disease-Specific Health-Related Quality-of-Life Instruments for Children With Immune Thrombocytopenic Purpura and Their Parents

  2003cited by this paper
• Grading of hemorrhage in children with idiopathic thrombocytopenic purpura.

  2002cited by this paper
• Management of childhood idiopathic thrombocytopenic purpura

  1999cited by this paper

• The Immune Thrombocytopenia Treatment Landscape: A Focus on Patient Perspectives and Unmet Clinical Needs

  2024cites this paper
• Association of depression and social anxiety symptom scores with disease characteristics in pediatric patients with chronic immune thrombocytopenia: a cross-sectional study

  2024cites this paper
• Efficacy and Safety Analysis of Combination Therapy Consisting of Intravenous Immunoglobulin and Corticosteroids versus Respective Monotherapies in the Treatment of Relapsed ITP in Adults

  2023influential citation
• Prediction of the Clinical Course of Immune Thrombocytopenia in Children by Platelet Kinetics

  2023cites this paper
• Missing Cells-A Rare Case of Persisting Thrombocytopenia in Pregnancy With Dengue and Role of Romiplostim in These Cases

  2023cites this paper
• Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study

  2022cites this paper
• Diagnosis and treatment of immune thrombocytopenia in Poland

  2022cites this paper
• Management of immune thrombocytopenia: 2022 update of Korean experts recommendations

  2022cites this paper
• Bleeding Associated with Thrombocytopenia

  2021cites this paper
• First report on health-related quality of life among children with chronic immune thrombocytopenia in Vietnam

  2021cites this paper
• Immune thrombocytopenic purpura secondary to SARS-CoV-2 infection in a child with acute lymphoblastic leukaemia: a case report and review of literature

  2021cites this paper
• Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand

  2021cites this paper
• Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol

  2021cites this paper
• Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia

  2021cites this paper
• Pediatric immune thrombocytopenia (ITP) treatment

  2021cites this paper
• Quality of life is an important indication for second‐line treatment in children with immune thrombocytopenia

  2021cites this paper
• Measuring parent proxy-reported quality of life of 11 rare diseases in children in Zhejiang, China

  2020cites this paper
• IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP.

  2020cites this paper
• The Cost-Effectiveness of Eltrombopag for the Treatment of Immune Thrombocytopenia in the United States.

  2020cites this paper
• Fatigue, executive function and psychological effects in children with immune thrombocytopenia: a cross‐sectional study

  2020cites this paper
• Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life

  2020cites this paper
• American Society of Hematology 2019 guidelines for immune thrombocytopenia.

  2019influential citation
• Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi‐institutional review

  2019influential citation
• Epidemiology and Clinical Manifestations of Immune Thrombocytopenia

  2019cites this paper
• A Narrative Approach to Describe QoL in Children With Chronic ITP

  2019cites this paper
• Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants

  2018cites this paper
• Health-Related Quality of Life in Patients with Immune Thrombocytopenia

  2018cites this paper
• Immune thrombocytopenia: improving quality of life and patient outcomes

  2018cites this paper
• Psychiatric Disorders and Quality of Life in Egyptian Patients with Chronic Immune Thrombocytopenic Purpura: A Single Center Study

  2018cites this paper
• Patterns and influences in health‐related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP Cohort

  2017cites this paper
• When and how to treat childhood immune thrombocytopenia.

  2016cites this paper
• Health-related quality of life in children with chronic immune thrombocytopenia in China

  2016cites this paper
• Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review

  2015cites this paper
• The psychological profile of children with immune thrombocytopenia and the factors influencing well-being

  2015cites this paper
• Newly diagnosed immune thrombocytopenic purpura in childhood: successful implementation of a limited intervention strategy in the setting of pediatric emergency care.

  2015cites this paper
• Bleeding complications in immune thrombocytopenia.

  2015cites this paper
• UvA-DARE ( Digital Academic Repository ) Pediatric immune thrombocytopenia : Catching platelets

  2014cites this paper
• Health-related Quality of Life of Egyptian Children With Immune Thrombocytopenia and Their Parents

  2014cites this paper
• Health-related quality of life in children with newly diagnosed immune thrombocytopenia

  2014cites this paper
• ITP-QoL Questionnaire for Children with Immune Thrombocytopenia: Italian Version validation's

  2014cites this paper
• A review of the management of childhood immune thrombocytopenia: how can we provide an evidence‐based approach?

  2014cites this paper
• Bleeding severity as an important outcome in childhood immune thrombocytopenia

  2013cites this paper
• The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP)

  2013cites this paper
• Evaluation of health related quality of life in children with immune thrombocytopenia with the PedsQL™ 4.0 Generic Core Scales: a study on behalf of the pays de Loire pediatric hematology network

  2013cites this paper
• Quality of life in immune thrombocytopenia following treatment

  2013cites this paper
• Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia

  2012cites this paper
• An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura.

  2012influential citation
• Analysis of Health-related Quality of Life in Children with Immune Thrombocytopenia and Their Parents Using the Kids’ ITP Tools

  2012cites this paper
• Original article SelectivevalidationoftheWHOBleedingScalein patients with chronic immune thrombocytopenia

  2012cites this paper
• Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters

  2011cites this paper
• Evaluating Bleeding Severity in Children with newly Diagnosed Immune Thrombocytopenia: A Pilot Study

  2010cites this paper
• Consensus Paper—ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia

  2010cites this paper
• Future research in ITP: an ICIS consensus

  2010cites this paper
• Challenges and priorities for patients with immune thrombocytopenic purpura and their physicians

  2009cites this paper
• Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS).

  2009cites this paper